Skip to main content
. Author manuscript; available in PMC: 2011 May 4.
Published in final edited form as: DNA Repair (Amst). 2010 Feb 25;9(5):478–487. doi: 10.1016/j.dnarep.2010.01.011

Fig. 6.

Fig. 6

No hRad9 foci formation in MMR defective HCT15 and LoVo cells following MNNG treatment. (A) HCT15 cells which contain MSH6 frame-shift mutation were untreated (upper panel) or treated with 10 µM MNNG in the presence of O6-BG (lower panel). Immunofluorence staining was performed similarly to Fig. 5. (B) LoVo cells which contain a large deletion in MSH2 gene and unstable MSH6 were untreated (upper panel) or treated with 10 µM MNNG in the presence of O6-BG (lower panel). Immunofluorence staining was performed similarly to Fig. 5. IV is the merge image of II and III. VIII is the merge image of VI and VII.